Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$41.57
-2.1%
$39.04
$26.56
$50.85
$1.20B0.8474,569 shs264,079 shs
Paragon 28, Inc. stock logo
FNA
Paragon 28
$13.11
+0.1%
$13.11
$4.65
$13.13
$1.10B1.471.18 million shs19.38 million shs
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
$14.54
-0.4%
$14.88
$8.26
$19.41
$1.24B-0.011.52 million shs1.69 million shs
Outset Medical, Inc. stock logo
OM
Outset Medical
$17.42
-1.0%
$19.25
$5.85
$62.10
$308.68M2.15209,795 shs319,092 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-2.77%-7.66%+13.47%+34.98%-10.67%
Paragon 28, Inc. stock logo
FNA
Paragon 28
0.00%0.00%0.00%+0.08%+54.00%
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
+2.89%+3.18%+7.43%+6.41%+28.80%
Outset Medical, Inc. stock logo
OM
Outset Medical
-2.76%-14.60%-7.07%+59.85%-73.51%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
2.204 of 5 stars
3.41.00.00.02.12.50.6
Paragon 28, Inc. stock logo
FNA
Paragon 28
N/AN/AN/AN/AN/AN/AN/AN/A
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
3.2464 of 5 stars
4.50.00.00.01.84.20.6
Outset Medical, Inc. stock logo
OM
Outset Medical
1.4601 of 5 stars
3.51.00.00.02.20.80.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
2.83
Moderate Buy$54.8331.91% Upside
Paragon 28, Inc. stock logo
FNA
Paragon 28
2.20
Hold$12.75-2.71% Downside
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
3.00
Buy$26.8984.93% Upside
Outset Medical, Inc. stock logo
OM
Outset Medical
3.00
Buy$29.5069.35% Upside

Current Analyst Ratings Breakdown

Latest OM, ESTA, LQDA, and FNA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/16/2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$58.00 ➝ $70.00
7/14/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$37.00
7/9/2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$38.00 ➝ $47.00
6/13/2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$48.00
6/12/2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$23.00 ➝ $25.00
6/11/2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$25.00 ➝ $23.00
6/2/2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/28/2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Outperform ➝ Sector Outperform$36.00 ➝ $37.00
5/28/2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$20.00 ➝ $23.00
5/28/2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$25.00
5/28/2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$29.00 ➝ $35.00
(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$166.02M7.24N/AN/A$1.90 per share21.88
Paragon 28, Inc. stock logo
FNA
Paragon 28
$256.18M4.29N/AN/A$2.05 per share6.39
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
$14M88.79N/AN/A$0.91 per share15.98
Outset Medical, Inc. stock logo
OM
Outset Medical
$113.69M2.72N/AN/A$7.49 per share2.33
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$84.60M-$3.10N/AN/AN/A-52.34%-196.25%-26.64%8/5/2025 (Estimated)
Paragon 28, Inc. stock logo
FNA
Paragon 28
-$57.53M-$0.63N/AN/AN/A-25.31%-37.90%-18.22%N/A
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
-$130.39M-$1.58N/AN/AN/A-903.80%-177.91%-60.15%8/6/2025 (Estimated)
Outset Medical, Inc. stock logo
OM
Outset Medical
-$127.98M-$29.15N/AN/A-98.74%-143.62%-37.50%8/6/2025 (Estimated)

Latest OM, ESTA, LQDA, and FNA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
-$0.43N/AN/AN/A$3.90 millionN/A
8/6/2025Q2 2025
Outset Medical, Inc. stock logo
OM
Outset Medical
-$1.76N/AN/AN/A$29.40 millionN/A
8/5/2025Q2 2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$0.54N/AN/AN/A$50.80 millionN/A
5/8/2025Q1 2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
-$0.42-$0.45-$0.03-$0.45$3.23 million$3.12 million
5/7/2025Q1 2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$0.83-$0.70+$0.13-$0.70$41.15 million$41.38 million
5/7/2025Q1 2025
Outset Medical, Inc. stock logo
OM
Outset Medical
-$0.97-$3.66-$2.69-$3.66$27.81 million$29.75 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
N/AN/AN/AN/AN/A
Paragon 28, Inc. stock logo
FNA
Paragon 28
N/AN/AN/AN/AN/A
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
N/AN/AN/AN/AN/A
Outset Medical, Inc. stock logo
OM
Outset Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
5.72
3.36
2.05
Paragon 28, Inc. stock logo
FNA
Paragon 28
0.79
3.50
1.60
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
2.08
2.93
2.91
Outset Medical, Inc. stock logo
OM
Outset Medical
0.57
8.37
6.74

Institutional Ownership

CompanyInstitutional Ownership
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
72.91%
Paragon 28, Inc. stock logo
FNA
Paragon 28
63.57%
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
64.54%
Outset Medical, Inc. stock logo
OM
Outset Medical
N/A

Insider Ownership

CompanyInsider Ownership
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
11.09%
Paragon 28, Inc. stock logo
FNA
Paragon 28
15.32%
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
26.50%
Outset Medical, Inc. stock logo
OM
Outset Medical
2.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
1,01828.92 million25.71 millionOptionable
Paragon 28, Inc. stock logo
FNA
Paragon 28
343,00083.94 million70.89 millionOptionable
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
5085.49 million62.83 millionOptionable
Outset Medical, Inc. stock logo
OM
Outset Medical
52017.72 million17.30 millionNot Optionable

Recent News About These Companies

Outset Medical, Inc. (OM) - Yahoo Finance

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Establishment Labs stock logo

Establishment Labs NASDAQ:ESTA

$41.57 -0.88 (-2.07%)
Closing price 04:00 PM Eastern
Extended Trading
$41.67 +0.10 (+0.24%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Paragon 28 stock logo

Paragon 28 NYSE:FNA

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

Liquidia Technologies stock logo

Liquidia Technologies NASDAQ:LQDA

$14.54 -0.06 (-0.41%)
Closing price 04:00 PM Eastern
Extended Trading
$14.54 0.00 (0.00%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Outset Medical stock logo

Outset Medical NASDAQ:OM

$17.42 -0.18 (-1.02%)
Closing price 04:00 PM Eastern
Extended Trading
$17.40 -0.02 (-0.11%)
As of 04:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.